Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Fiebigera W et al. – The occurrence of NETs/undifferentiated neuroendocrine carcinomas following organ transplantation appears to be rare, with an incidence comparable with the normal population. Our data suggest a highly aggressive course with a dismal prognosis and unresponsiveness to chemotherapy.
Methods- Retrospectively analyzed patients undergoing organ transplantation between 1985 and 2001 in order to assess the frequency and clinical course of NETs in organ transplant recipients
- 3,190 organ transplant recipients with sufficient clinical data identified (2,521 kidney and 669 heart transplants)
- In total, 161/3,190 patients (5%) developed malignancies, with 6 of them being classified as NETs (0.18%)
- Interestingly, all 6 patients diagnosed with undifferentiated neuroendocrine carcinomas, while no indolent NETs seen
- 4 of these patients had undergone renal, 1 patient heart and 1 patient both heart and renal transplantation
- All 6 patients given chemotherapy, but none of them responded, as all patients showed disease progression after median of 3 cycles of chemotherapy (range 1-4) with the median survival being 4.8 months (range 2-11)
Related Articles
Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center
Medical Oncology, 11/19/09
Relevance Score: 67%
Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09
Relevance Score: 67%
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Relevance Score: 66%
High-dose Octreotide Acetate for Management of Gastroenteropancreatic Neuroendocrine Tumors
Anticancer Research, 11/11/09
Relevance Score: 66%
Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols
American Journal of Roentgenology, 10/08/09
Relevance Score: 66%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients
Acta Diabetologia, 02/09/10
The development of a sleep apnea screening program in Romanian type 2 diabetic patients: a pilot study
Acta Diabetologia, 02/09/10
Glucose tolerance, insulin resistance and insulin secretion in young south Indian adults: Relationships to parental size, neonatal size and childhood body mass index
Diabetes Research and Clinical Practice, 02/09/10
Article Search
Sponsor
Sponsor


See Latest Articles


